Drug Information

Drug General Information
Drug ID
D0C1WL
Former ID
DIB000200
Drug Name
C-2507
Synonyms
C-2507; L-0008708100; L-870810; L-870812; L-900564; HIV integrase inhibitors, Merck & Co; Integric acid, Merck & Co
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 1 [532094]
Company
Merck & Co Inc
Structure
Download
2D MOL

3D MOL
Formula
C11H20F6N2O7S3
Canonical SMILES
S1(=O)(=O)N(c2nc(c(c3c2cccn3)O)C(=O)NCc2c(C(=O)NC)cc(cc<br />2)F)CCCC1
CAS Number
CAS 422550-94-5
PubChem Compound ID
56973024
Target and Pathway
Target(s) HIV integrase Target Info Inhibitor [530462]
References
Ref 532094Repositioning HIV-1 integrase inhibitors for cancer therapeutics: 1,6-naphthyridine-7-carboxamide as a promising scaffold with drug-like properties. J Med Chem. 2012 Nov 26;55(22):9492-509.
Ref 530462Elvitegravir: a new HIV integrase inhibitor. Antivir Chem Chemother. 2009 Oct 19;20(2):79-85.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.